Trial Outcomes & Findings for Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study (NCT NCT03998462)

NCT ID: NCT03998462

Last Updated: 2025-11-18

Results Overview

Parkinson's disease Quality of Life (PDQ-39); Total Score = 0-156; higher score = worse quality of life.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

107 participants

Primary outcome timeframe

pre- to post-intervention (0 to 9 weeks)

Results posted on

2025-11-18

Participant Flow

Participant milestones

Participant milestones
Measure
Mindfulness Based Stress Reduction (MBSR)
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Overall Study
STARTED
52
51
Overall Study
COMPLETED
40
45
Overall Study
NOT COMPLETED
12
6

Reasons for withdrawal

Reasons for withdrawal
Measure
Mindfulness Based Stress Reduction (MBSR)
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Overall Study
Withdrawal by Subject
10
4
Overall Study
Lost to Follow-up
1
0
Overall Study
Technical Difficulties
1
2

Baseline Characteristics

Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mindfulness Based Stress Reduction (MBSR)
n=52 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
n=51 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Total
n=103 Participants
Total of all reporting groups
Age, Continuous
68.1 years
STANDARD_DEVIATION 7.44 • n=202 Participants
69.8 years
STANDARD_DEVIATION 8.3 • n=283 Participants
68.98 years
STANDARD_DEVIATION 7.895 • n=120 Participants
Sex: Female, Male
Female
23 Participants
n=202 Participants
20 Participants
n=283 Participants
43 Participants
n=120 Participants
Sex: Female, Male
Male
29 Participants
n=202 Participants
31 Participants
n=283 Participants
60 Participants
n=120 Participants
Race/Ethnicity, Customized
Ethnicity · Non-Hispanic
46 Participants
n=202 Participants
48 Participants
n=283 Participants
94 Participants
n=120 Participants
Race/Ethnicity, Customized
Ethnicity · Hispanic
6 Participants
n=202 Participants
3 Participants
n=283 Participants
9 Participants
n=120 Participants

PRIMARY outcome

Timeframe: pre- to post-intervention (0 to 9 weeks)

Parkinson's disease Quality of Life (PDQ-39); Total Score = 0-156; higher score = worse quality of life.

Outcome measures

Outcome measures
Measure
Mindfulness Based Stress Reduction (MBSR)
n=52 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
n=51 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Parkinson's Disease Questionnaire-39
-1.03 change score
Standard Deviation 9.71
-3.04 change score
Standard Deviation 7.94

SECONDARY outcome

Timeframe: pre- to post-intervention (0 to 9 weeks)

Test My Brain (TMB) Matrix Reasoning Test (MRT); Total Score = 0-36; higher score = better performance.

Outcome measures

Outcome measures
Measure
Mindfulness Based Stress Reduction (MBSR)
n=52 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
n=51 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Matrix Reasoning Test
0.154 change score
Standard Deviation 6.54
1.04 change score
Standard Deviation 5.92

SECONDARY outcome

Timeframe: pre- to post-intervention (0 to 9 weeks)

State-Trait Anxiety Inventory - Trait Subscale (STAI-Trait); 20-80; higher score = higher levels of anxiety.

Outcome measures

Outcome measures
Measure
Mindfulness Based Stress Reduction (MBSR)
n=52 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
n=51 Participants
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
State-Trait Anxiety Inventory
-1.40 change score
Standard Deviation 4.51
-1.84 change score
Standard Deviation 5.28

Adverse Events

Mindfulness Based Stress Reduction (MBSR)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Psychoeducational Supportive Care (PSC)

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Mindfulness Based Stress Reduction (MBSR)
n=52 participants at risk
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. The MBSR intervention was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, all MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Psychoeducational Supportive Care (PSC)
n=51 participants at risk
Individuals with Parkinson's disease were randomly assigned to one of two study arms: MBSR or PSC. PSC is a novel intervention developed by Schiehser and colleagues to serve as a control for MBSR in this trial. PSC was modeled after common support/education groups that provide support and psychoeducation about Parkinson's disease available in the community. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.
Injury, poisoning and procedural complications
injury during session while performing unprescribed exercise
0.00%
0/52 • during intervention (~9 weeks)
2.0%
1/51 • Number of events 1 • during intervention (~9 weeks)

Additional Information

Dr. Dawn Schiehser, Ph.D.

North Florida/South Georgia VA Healthcare System

Phone: 352-376-1611

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place